Search

everythinglearnresearchcommunity

for

Search:↓

Mycophenolic acid may help hair growth, a combination treatment improves hair thickness in male hair loss, and early treatment of frontal fibrosing alopecia is important.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

Alopecia patients have less GPER-1, which might affect hair loss.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Hair loss caused by genetics and hormones; more research needed for treatments.

Platelet Rich Plasma can potentially help in restoring hair loss, but more research with larger groups is needed to confirm its effectiveness and standardize its use.

Finasteride helps female-pattern hair loss.

Topical minoxidil helps treat hair loss in teens, but more research needed for safe options.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

Finasteride effectively treats hair loss in men with minimal side effects.

Treatments for hair loss include hormone modifiers, minoxidil, and hair transplant surgery.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Most cases of Temporal Triangular Alopecia are found in early childhood and may be related to genetic conditions.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Vitiligo is not linked to coeliac disease, but a small number of alopecia areata patients may have it, suggesting they should be tested for coeliac disease.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.